You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

e - Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Company Disclosures: US Patents for e

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Immunex Corporation (Seattle, WA)	2012-03-07	RX	Orphan	company
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Immunex Corporation (Seattle, WA)	2014-02-25	RX	Orphan	company
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Immunex Corporation (Seattle, WA)	2009-09-05	RX	Orphan	company
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Immunex Corporation (Seattle, WA)	2009-09-11	RX	Orphan	company
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial		2009-09-05	RX	Orphan	company
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Immunex Corporation (Seattle, WA)	2009-09-05	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for e

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX	Orphan	search
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	ForSight Vision4, Inc. (Menlo Park, CA)	2029-01-29	RX	Orphan	search
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	Forsight Vision4, Inc. (Menlo Park, CA)	2029-01-29	RX	Orphan	search
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	Shire Human Genetic Therapies, Inc. (Lexington, MA)	2031-06-08	RX	Orphan	search
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX	Orphan	search
Shire	ELAPRASE	idursulfase	INJECTABLE; IV (INFUSION)	125151	001	2006-07-24	Start Trial	Shire Human Genetic Therapies, Inc. (Lexington, MA)	2031-06-08	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Express Scripts

Johnson and Johnson

AstraZeneca

Colorcon

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.